Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
United Bankshares
UBSI
$6.66B
| $4.87M | 0.01% |
140,104
+43,900
| +46% | +$1.58M |
|
1827
Jakks Pacific
JAKK
$288M
| $4.86M | 0.01% |
206,950
+18,210
| +10% | +$505K |
|
1828
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $4.85M | 0.01% |
+58,700
| New | +$4.84M |
|
1829
Citizens & Northern Corp
CZNC
$466M
| $4.85M | 0.01% |
202,069
+3,404
| +2% | +$84.9K |
|
|
NOA
1830
North American Construction
NOA
$414M
| $4.85M | 0.01% |
979,800
+23,200
| +2% | +$102K |
|
1831
Gyre Therapeutics
GYRE
$706M
| $4.85M | 0.01% |
47,383
+2,880
| +6% | +$147K |
|
|
AAWW
1832
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $4.84M | 0.01% |
82,600
-150,400
| -65% | -$8.97M |
|
|
EHIC
1833
DELISTED
eHi Car Services Limited
EHIC
| $4.84M | 0.01% |
418,100
+156,100
| +60% | +$1.74M |
|
|
SYNT
1834
DELISTED
Syntel Inc
SYNT
| $4.83M | 0.01% |
210,290
-3,900
| -2% | -$92.4K |
|
|
TAST
1835
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $4.83M | 0.01% |
397,300
+35,200
| +10% | +$418K |
|
|
MANT
1836
DELISTED
Mantech International Corp
MANT
| $4.82M | 0.01% |
96,100
+26,000
| +37% | +$1.26M |
|
|
CNXM
1837
DELISTED
CNX Midstream Partners LP
CNXM
| $4.82M | 0.01% |
287,574
+72,574
| +34% | +$1.21M |
|
|
PWOD
1838
DELISTED
Penns Woods Bancorp
PWOD
| $4.82M | 0.01% |
155,250
-300
| -0.2% | -$9.58K |
|
1839
Pembina Pipeline
PBA
$28.4B
| $4.81M | 0.01% |
132,470
+123,106
| +1,315% | +$4.26M |
|
1840
Superior Group of Companies
SGC
$213M
| $4.79M | 0.01% |
179,500
-900
| -0.5% | -$22.1K |
|
1841
Hudbay
HBM
$11.8B
| $4.79M | 0.01% |
542,882
+497,182
| +1,088% | +$3.88M |
|
1842
City Holding Co
CHCO
$2.08B
| $4.79M | 0.01% |
71,000
-41,900
| -37% | -$2.92M |
|
|
MSL
1843
DELISTED
Midsouth Bancorp, Inc.
MSL
| $4.78M | 0.01% |
361,009
+50,811
| +16% | +$668K |
|
1844
Scansource
SCSC
$1.06B
| $4.78M | 0.01% |
+133,570
| New | +$5.22M |
|
1845
Cardinal Health
CAH
$54.5B
| $4.77M | 0.01% |
+77,900
| New | +$4.82M |
|
|
ZOES
1846
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $4.77M | 0.01% |
285,400
+222,000
| +350% | +$3.11M |
|
|
FFWM
1847
DELISTED
First Foundation Inc
FFWM
| $4.75M | 0.01% |
256,396
+27,091
| +12% | +$500K |
|
1848
First Bancorp
FNLC
$402M
| $4.75M | 0.01% |
174,400
+6,100
| +4% | +$182K |
|
1849
Standard BioTools
LAB
$312M
| $4.74M | 0.01% |
805,300
+134,700
| +20% | +$737K |
|
1850
Silicon Laboratories
SLAB
$7.3B
| $4.74M | 0.01% |
53,698
+49,000
| +1,043% | +$4.4M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.